Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation

Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer

1017.9500 22.00 (2.21%)

NSE Jul 11, 2025 15:31 PM

25.15% Fall from 52W High

Volume: 322.1K

Cohance Lifesciences Ltd.

29 Feb 2024

1017.95

2.21%

Investor Presentation

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation

More from Cohance Lifescien…

All earning calls

Investor presentations from Cohance Lifescien…

All investor presentations